Locus 132: GCDH (19p13.13)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs8012 |
glutaroyl carnitine |
A/G |
7256 |
0.44 |
0.037 (0.003) |
6.36·10-45 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs8012 |
| Chromosomal location | Chr19: 12,871,520 (19p13.13) |
| Gene (distance) | GCDH (0) |
| Predicted causal gene | GCDH |
| Gene/protein classification | - |
| Metabolite (Pathway) | glutaroyl carnitine (Lysine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | GCDH encodes glutaryl-CoA dehydrogenase which catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA [3081514]. Acyl-carnitines and acyl-CoAs readily interconvert |
| eQTL associations | GCDH (F), GCDH (L), GCDH (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | Glutaric acidemia type 1. |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

